[TIMECOM] QoQ TTM Result on 30-Jun-2021 [#2]

Stock
[TIMECOM] TIME DOTCOM BHD
Announcement Date
27-Aug-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2021
Quarter
30-Jun-2021 [#2]
Profit Trend
QoQ- 7.12%
YoY- 5.57%
Quarter Report
Latest QR
Upcoming QR
TIMECOM's Result
TIMECOM's Financial Summary
View:
Show?
TTM Result
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Revenue 1,434,382 1,396,362 1,340,154 1,302,930 1,260,553 1,223,169 1,203,640 12.41%
PBT 530,622 532,724 497,362 450,495 422,920 423,098 393,684 22.04%
Tax -134,146 -135,946 -117,478 -106,448 -102,357 -96,194 -84,621 35.99%
NP 396,476 396,778 379,884 344,047 320,563 326,904 309,063 18.08%
-
NP to SH 392,452 393,160 378,923 344,325 321,438 328,047 309,101 17.27%
-
Tax Rate 25.28% 25.52% 23.62% 23.63% 24.20% 22.74% 21.49% -
Total Cost 1,037,906 999,584 960,270 958,883 939,990 896,265 894,577 10.42%
-
Net Worth 3,012,271 3,105,933 3,145,235 3,041,424 2,942,755 3,045,479 2,946,953 1.47%
Dividend
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Div 385,894 385,894 200,010 200,010 200,010 200,010 169,980 72.82%
Div Payout % 98.33% 98.15% 52.78% 58.09% 62.22% 60.97% 54.99% -
Equity
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Net Worth 3,012,271 3,105,933 3,145,235 3,041,424 2,942,755 3,045,479 2,946,953 1.47%
NOSH 1,825,618 1,825,618 1,825,618 604,711 604,261 604,261 604,261 109.12%
Ratio Analysis
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
NP Margin 27.64% 28.42% 28.35% 26.41% 25.43% 26.73% 25.68% -
ROE 13.03% 12.66% 12.05% 11.32% 10.92% 10.77% 10.49% -
Per Share
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
RPS 78.57 77.33 73.71 215.48 208.61 202.42 199.32 -46.26%
EPS 21.50 21.77 20.84 56.95 53.20 54.29 51.19 -43.94%
DPS 21.14 21.37 11.00 33.10 33.10 33.10 28.15 -17.39%
NAPS 1.65 1.72 1.73 5.03 4.87 5.04 4.88 -51.49%
Adjusted Per Share Value based on latest NOSH - 604,711
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
RPS 77.58 75.53 72.49 70.47 68.18 66.16 65.10 12.41%
EPS 21.23 21.27 20.50 18.62 17.39 17.74 16.72 17.27%
DPS 20.87 20.87 10.82 10.82 10.82 10.82 9.19 72.85%
NAPS 1.6293 1.68 1.7012 1.6451 1.5917 1.6473 1.594 1.47%
Price Multiplier on Financial Quarter End Date
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Date 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 -
Price 4.30 4.60 4.55 14.06 14.30 13.26 12.00 -
P/RPS 5.47 5.95 6.17 6.52 6.85 6.55 6.02 -6.19%
P/EPS 20.00 21.13 21.83 24.69 26.88 24.42 23.44 -10.04%
EY 5.00 4.73 4.58 4.05 3.72 4.09 4.27 11.10%
DY 4.92 4.65 2.42 2.35 2.31 2.50 2.35 63.72%
P/NAPS 2.61 2.67 2.63 2.80 2.94 2.63 2.46 4.02%
Price Multiplier on Announcement Date
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Date 30/05/22 25/02/22 26/11/21 27/08/21 28/05/21 26/02/21 26/11/20 -
Price 4.43 4.13 4.34 4.65 13.98 13.90 14.00 -
P/RPS 5.64 5.34 5.89 2.16 6.70 6.87 7.02 -13.58%
P/EPS 20.61 18.97 20.82 8.17 26.28 25.60 27.35 -17.20%
EY 4.85 5.27 4.80 12.25 3.81 3.91 3.66 20.66%
DY 4.77 5.17 2.53 7.12 2.37 2.38 2.01 78.00%
P/NAPS 2.68 2.40 2.51 0.92 2.87 2.76 2.87 -4.46%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment